NCT06028165 CABG Based on CT-FFR Versus Conventional Coronary Angiography
| NCT ID | NCT06028165 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Myongji Hospital |
| Condition | Coronary Artery Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 96 participants |
| Start Date | 2023-10-20 |
| Primary Completion | 2024-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 96 participants in total. It began in 2023-10-20 with a primary completion date of 2024-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aims of study are (1) to compare early and 1-year graft patency rates in patients who underwent coronary artery bypass grafting (CABG) based on conventional coronary angiography(CAG) versus cardiac computed tomography(CT)-derived fractional flow reserve(FFR), and (2) to demonstrate difference in clinical outcomes between the 2 groups.
Eligibility Criteria
Inclusion Criteria: * age equal or more than 40 * age equal or less than 80 * patients who undergo coronary artery bypass grafting due to multi-vessel coronary artery disease * patients who agree to the enrollment Exclusion Criteria: * Patients with heart failure (left ventricular ejection fraction \< 25%) * patients who have intractable ventricular arrhythmia * patients who has been treated for cancer * patients who has infectious disease * patients who are planned to undergo combined cardiac surgery * patients who has medical co-morbidity with expected survival less than 1 year * patients with a history of previous cardiac surgery * Patients with chronic renal failure requiring dialysis * patients who undergo emergency operation
Contact & Investigator
Min-Seok Kim, MD, PhD, MSc
STUDY CHAIR
Cardiovascular Center, Myongji Hospital
Frequently Asked Questions
Who can join the NCT06028165 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Coronary Artery Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06028165 currently recruiting?
Yes, NCT06028165 is actively recruiting participants. Contact the research team at minseok.kim.md.phd@gmail.com for enrollment information.
Where is the NCT06028165 trial being conducted?
This trial is being conducted at Goyang-si, South Korea.
Who is sponsoring the NCT06028165 clinical trial?
NCT06028165 is sponsored by Myongji Hospital. The principal investigator is Min-Seok Kim, MD, PhD, MSc at Cardiovascular Center, Myongji Hospital. The trial plans to enroll 96 participants.